Market capitalization of Capricor Therapeutics (CAPR)

Market cap: NZ$1.07 Billion

As of October 2024 Capricor Therapeutics has a market cap of NZ$1.07 Billion. This makes Capricor Therapeutics the world's 6230th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of Capricor Therapeutics was reported to be:

NZ$1.07 Billion

by Yahoo Finance

NZ$1.07 Billion

by CompaniesMarketCap

NZ$0.99 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Cytokinetics CYTK	NZ$10.57 B	881.96%	🇺🇸 USA
Palatin Technologies PTN	NZ$32.23 M	-97.01%	🇺🇸 USA
Johnson & Johnson JNJ	NZ$652.87 B	60,494.69%	🇺🇸 USA
Neurocrine Biosciences NBIX	NZ$19.72 B	1,730.70%	🇺🇸 USA
Celldex Therapeutics CLDX	NZ$3.14 B	191.57%	🇺🇸 USA
Eterna Therapeutics ERNA	NZ$9.54 M	-99.11%	🇺🇸 USA